CD4 and cancer: In addition, the study demonstrated that tumor cell-derived exosomes can deliver miR-214 to CD4 T cells in human cancers, which ultimately reduced phosphatase and tensin homolog production and accelerated Treg cell expansion and tumor growth (45).